Understanding how astrocytes are involved in HIV-Tat-induced Alzheimer’s-like pathology, leading to cognitive deficits and unraveling the therapeutic potential of HIF-1α in this process, is a novel concept and could be the basis for the future development of therapeutics aimed at treating the cognitive impairment (s) associated with HAND. Here, TAT is linked to HIV-associated neurocognitive disorder.